Home > Formulary : Paediatric > Recent Decisions > 2021 >
Decisions 14th September 2021
At the meeting on the 14th September the following decisions were agreed
New Drug Requests
Approved
Ranibizumab (Lucentis) (TLS Red)
-
For the treatment of retinopathy of prematurity disease in preterm babies